Please login to the form below

Not currently logged in
Email:
Password:

Novartis changes executive committee

Robert Welteverden is appointed head of Novartis Business Services

NovartisRobert Welteverden has been appointed head of Novartis Business Services (NBS), a role that will see him become a member of the executive committee and report into chief executive officer Vas Narasimhan.

Welteverden, who was previously head of business services for Syngenta, will join Novartis’ Basel base in Switzerland.

Narasimhan, said: “Robert’s deep understanding of business services coupled with his strong financial and commercial acumen make him the right person to lead NBS in the next stage of its evolution.

“Over the coming years, he will play a critical role in driving even higher levels of productivity and process standardisation across Novartis and I am confident that under his leadership, our NBS team will be able to unlock even greater value for us to reinvest in innovation and our exciting product pipeline.”

Additionally, Felix Ehrat, Novartis’ group general counsel has retired from the company and Shannon Thyme Klinger, currently chief ethics, risk and compliance officer, will succeed him.

Klinger initially joined Novartis back in 2011 as general counsel, North America for its biopharmaceutical arm Sandoz.

Commenting on her promotion, Narasimhan said: “Shannon has a proven track record as a strong thought leader with a commitment to ethics and integrity.

“She brings the combination of private practice and industry experience in Europe and the US that we need, and I have no doubt that the company will benefit from her judgment and expertise."

Lastly, Natacha Theytaz, global head internal audit will lead the ethics, risk and compliance organisation ad interim.

Theytaz joins the Swiss pharma giant from Roche, where she was chief audit and risk advisory executive.

30th May 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mednet Group

Communique Small consultancy of the year 2020. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....